Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Ubn2 | Mouse | 1,2-dichloroethane | decreases expression | EXP | | 6480464 | ethylene dichloride results in decreased expression of UBN2 mRNA | CTD | PMID:28960355 | Ubn2 | Mouse | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBN2 mRNA | CTD | PMID:22206623 | Ubn2 | Mouse | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | EXP | | 6480464 | [2 more ... | CTD | PMID:25510870 | Ubn2 | Mouse | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | EXP | | 6480464 | [2 more ... | CTD | PMID:25510870 | Ubn2 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | UBN2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of UBN2 mRNA | CTD | PMID:22574217 | Ubn2 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Ubn2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of UBN2 mRNA | CTD | PMID:33387578 | Ubn2 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Ubn2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of UBN2 mRNA | CTD | PMID:32109520 and PMID:34747641 | Ubn2 | Mouse | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | ISO | Ubn2 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | Ubn2 | Mouse | 2,5-hexanedione | increases expression | ISO | Ubn2 (Rattus norvegicus) | 6480464 | 2 and 5-hexanedione results in increased expression of UBN2 mRNA | CTD | PMID:22952946 | Ubn2 | Mouse | 3,4-methylenedioxymethamphetamine | decreases expression | EXP | | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of UBN2 mRNA | CTD | PMID:20188158 | Ubn2 | Mouse | 3,4-methylenedioxymethamphetamine | affects expression | ISO | Ubn2 (Rattus norvegicus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine affects the expression of UBN2 mRNA | CTD | PMID:30071829 | Ubn2 | Mouse | 6-propyl-2-thiouracil | decreases expression | ISO | Ubn2 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of UBN2 mRNA | CTD | PMID:30047161 | Ubn2 | Mouse | acrylamide | decreases expression | ISO | Ubn2 (Rattus norvegicus) | 6480464 | Acrylamide results in decreased expression of UBN2 mRNA | CTD | PMID:28959563 | Ubn2 | Mouse | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of UBN2 mRNA | CTD | PMID:19770486 | Ubn2 | Mouse | amitrole | decreases expression | ISO | Ubn2 (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of UBN2 mRNA | CTD | PMID:30047161 | Ubn2 | Mouse | arsenite(3-) | multiple interactions | ISO | UBN2 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to UBN2 mRNA] | CTD | PMID:32406909 | Ubn2 | Mouse | bisphenol A | affects expression | ISO | Ubn2 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of UBN2 mRNA | CTD | PMID:25181051 | Ubn2 | Mouse | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of UBN2 mRNA | CTD | PMID:32156529 and PMID:38074096 | Ubn2 | Mouse | butanal | decreases expression | ISO | UBN2 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of UBN2 mRNA | CTD | PMID:26079696 | Ubn2 | Mouse | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | Ubn2 | Mouse | chloroprene | increases expression | ISO | Ubn2 (Rattus norvegicus) | 6480464 | Chloroprene results in increased expression of UBN2 mRNA | CTD | PMID:23125180 | Ubn2 | Mouse | chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of UBN2 mRNA | CTD | PMID:37019170 | Ubn2 | Mouse | clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of UBN2 mRNA | CTD | PMID:23811191 | Ubn2 | Mouse | copper atom | multiple interactions | ISO | UBN2 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of UBN2 mRNA | CTD | PMID:20971185 | Ubn2 | Mouse | copper(0) | multiple interactions | ISO | UBN2 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of UBN2 mRNA | CTD | PMID:20971185 | Ubn2 | Mouse | Dibutyl phosphate | affects expression | ISO | UBN2 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of UBN2 mRNA | CTD | PMID:37042841 | Ubn2 | Mouse | diethylstilbestrol | increases expression | ISO | UBN2 (Homo sapiens) | 6480464 | Diethylstilbestrol results in increased expression of UBN2 mRNA | CTD | PMID:36621641 | Ubn2 | Mouse | dorsomorphin | multiple interactions | ISO | UBN2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Ubn2 | Mouse | folic acid | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBN2 mRNA | CTD | PMID:22206623 | Ubn2 | Mouse | FR900359 | increases phosphorylation | ISO | UBN2 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of UBN2 protein | CTD | PMID:37730182 | Ubn2 | Mouse | geldanamycin | increases expression | ISO | UBN2 (Homo sapiens) | 6480464 | geldanamycin results in increased expression of UBN2 mRNA | CTD | PMID:26705709 | Ubn2 | Mouse | gentamycin | decreases expression | ISO | Ubn2 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of UBN2 mRNA | CTD | PMID:33387578 | Ubn2 | Mouse | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of UBN2 mRNA | CTD | PMID:25890327 | Ubn2 | Mouse | methimazole | decreases expression | ISO | Ubn2 (Rattus norvegicus) | 6480464 | Methimazole results in decreased expression of UBN2 mRNA | CTD | PMID:30047161 | Ubn2 | Mouse | methyl methanesulfonate | increases expression | ISO | UBN2 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of UBN2 mRNA | CTD | PMID:23649840 | Ubn2 | Mouse | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of UBN2 mRNA | CTD | PMID:34911549 | Ubn2 | Mouse | p-chloromercuribenzoic acid | decreases expression | ISO | UBN2 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of UBN2 mRNA | CTD | PMID:26272509 | Ubn2 | Mouse | paracetamol | increases expression | ISO | Ubn2 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of UBN2 mRNA | CTD | PMID:33387578 | Ubn2 | Mouse | PCB138 | multiple interactions | EXP | | 6480464 | [2 more ... | CTD | PMID:25510870 | Ubn2 | Mouse | phenylmercury acetate | decreases expression | ISO | UBN2 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of UBN2 mRNA | CTD | PMID:26272509 | Ubn2 | Mouse | phenylmercury acetate | multiple interactions | ISO | UBN2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBN2 mRNA | CTD | PMID:27188386 | Ubn2 | Mouse | pirinixic acid | multiple interactions | ISO | UBN2 (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of UBN2 mRNA | CTD | PMID:19710929 | Ubn2 | Mouse | pregnenolone 16alpha-carbonitrile | decreases expression | ISO | Ubn2 (Rattus norvegicus) | 6480464 | Pregnenolone Carbonitrile results in decreased expression of UBN2 mRNA | CTD | PMID:30047161 | Ubn2 | Mouse | SB 431542 | multiple interactions | ISO | UBN2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Ubn2 | Mouse | sodium arsenate | increases expression | EXP | | 6480464 | sodium arsenate results in increased expression of UBN2 mRNA | CTD | PMID:21795629 | Ubn2 | Mouse | sodium arsenite | increases expression | ISO | UBN2 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of UBN2 mRNA | CTD | PMID:38568856 | Ubn2 | Mouse | sulfadimethoxine | decreases expression | ISO | Ubn2 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in decreased expression of UBN2 mRNA | CTD | PMID:30047161 | Ubn2 | Mouse | sunitinib | increases expression | ISO | UBN2 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of UBN2 mRNA | CTD | PMID:31533062 | Ubn2 | Mouse | thimerosal | decreases expression | ISO | UBN2 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of UBN2 mRNA | CTD | PMID:27188386 | Ubn2 | Mouse | titanium dioxide | decreases methylation | EXP | | 6480464 | titanium dioxide results in decreased methylation of UBN2 gene | CTD | PMID:35295148 | Ubn2 | Mouse | triphenyl phosphate | affects expression | ISO | UBN2 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of UBN2 mRNA | CTD | PMID:37042841 | Ubn2 | Mouse | triptonide | increases expression | EXP | | 6480464 | triptonide results in increased expression of UBN2 mRNA | CTD | PMID:33045310 | Ubn2 | Mouse | tungsten | decreases expression | EXP | | 6480464 | Tungsten results in decreased expression of UBN2 mRNA | CTD | PMID:30912803 | Ubn2 | Mouse | urethane | increases expression | ISO | UBN2 (Homo sapiens) | 6480464 | Urethane results in increased expression of UBN2 mRNA | CTD | PMID:28818685 | Ubn2 | Mouse | valproic acid | affects expression | ISO | UBN2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of UBN2 mRNA | CTD | PMID:25979313 | Ubn2 | Mouse | valproic acid | affects splicing | ISO | Ubn2 (Rattus norvegicus) | 6480464 | Valproic Acid affects the splicing of UBN2 mRNA | CTD | PMID:29427782 | Ubn2 | Mouse | valproic acid | multiple interactions | ISO | UBN2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBN2 mRNA | CTD | PMID:27188386 | Ubn2 | Mouse | valproic acid | decreases expression | ISO | UBN2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of UBN2 mRNA | CTD | PMID:23179753 more ... | Ubn2 | Mouse | valproic acid | decreases methylation | ISO | UBN2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of UBN2 gene | CTD | PMID:29154799 | Ubn2 | Mouse | vinclozolin | affects expression | ISO | Ubn2 (Rattus norvegicus) | 6480464 | vinclozolin affects the expression of UBN2 mRNA | CTD | PMID:19015723 | Ubn2 | Mouse | vinclozolin | increases methylation | ISO | Ubn2 (Rattus norvegicus) | 6480464 | vinclozolin results in increased methylation of UBN2 gene | CTD | PMID:31682807 | Ubn2 | Mouse | vorinostat | decreases expression | ISO | UBN2 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of UBN2 mRNA | CTD | PMID:27188386 | |